Michael Burry boosted his positions in apparel, healthcare, and scientific stocks, while trimming major holdings, showing a ...

Fintel reports that on November 4, 2025, Barclays maintained coverage of Bruker (NasdaqGS:BRKR) with a Overweight ...

Bruker Corporation (Nasdaq: BRKR, BRKRP) today announced that its Board of Directors ("Board") has approved payment of a ...

Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the ...

According to a filing with the Securities and Exchange Commission released on Tuesday, Lane Generational sold its entire ...

Bruker’s stock price target has recently seen a slight uptick, with consensus analyst forecasts rising from $46.73 to $47.82. This modest increase signals renewed analyst confidence in the company’s ...

Bruker (BRKR) posted net profit margins of 2.3% for the period ending June 30, 2025, a steep drop from last year’s 11.3% margin, after booking a one-off loss of $176.3 million. Revenue is forecast to ...

Famed investor Michael Burry’s Scion Asset Management disclosed new bullish positions in Pfizer ( PFE ), Halliburton ( HAL ), ...

Bruker Corporation (NASDAQ: BRKR) delivered a sharp earnings beat this morning, lifting shares nearly 7% despite underlying ...

As of the third quarter of 2025, Michael Burry (Trades, Portfolio)'s portfolio included eight stocks. The top holdings were 1.73% in Molina Healthcare Inc (NYSE:MOH), 1.29% in Lululemon Athletica Inc ...

KalVista Pharmaceuticals, Inc. will host a conference call and webcast on Tuesday, November 11, 2025, at 8:30 a.m. ET to review the Company's third quarter financial results and provide an operational ...

Scientific instrument company Bruker (NASDAQ:BRKR). announced better-than-expected revenue in Q3 CY2025, but sales were flat ...